The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable for lawsuits associated with talc-based foot powder products obtained from Merck
In groundbreaking research published this month in the Journal of Dental Research, scientists from Rutgers University and the University of Texas revealed that CBD, a cannabis compound could offer a potent and safe alternative to opioids for managing acute dental pain
Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC.
Eli Lilly And Co (NYSE: LLY) reportedly intends to construct a production plant in western Germany with an estimated investment of €2 billion ($2.17 billion), marking an inaugural substantial production facility in Germany and responding to the increasing pressure to localize critical healthcare manu
SpringWorks Therapeutics Inc (NASDAQ: SWTX) released topline results from its Phase 2b ReNeu trial evaluating mirdametinib, an investigational MEK inhibitor, in pediatric and adult patients with NF1-associated